Researchers have produced a high-quality draft genome of the coffee plant, Coffea canephora. Using a combination of Sanger, Roche 454, and Illumina sequencing, they put together a 568.6 million base assembly that stretched over around 80 percent of the plant's 710 million base genome. Their analysis of the genome, combined with comparisons to sequences from related plants, uncovered several gene family expansions in coffee, including a boost in genes involved in plant defense and caffeine production.
Biocartis has raised around $84 million in a private round of financing that will support the firm's commercial roll-out of its Idylla molecular diagnostics platform in Europe later this year, and enable it to expand its commercial reach beyond Europe. The firm also formed a joint venture called MyCartis with protein diagnostics firm Pronota. Biocartis spun off its its DMAT platform, a multiplex system used for rapid and cost-effective detection of protein and nucleic acid biomarkers, to the JV.
Three US funding agencies, along with partners in the UK and Israel, will provide up to $12 million next year to support multidisciplinary research projects that will use genomics among other methods to better understand how infectious disease pathogens are transmitted and evolve. The projects will be funded under the Ecology and Evolution of Infectious Diseases program, and will aim to create quantitative or computational knowledge about and models of infectious disease transmission.
This online seminar will provide an overview of new tools for screening stem cells — in particular, the use of RNA detection probes to detect pluripotency gene expression in live embryonic and induced pluripotent stem cells by fluorescence microscopy without the need for manipulation of the cells.